Article
Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
Frontiers in cellular and infection microbiology - 1 Jan 2024
Wang Zihui, Li Shaoqiang, Cai Guannan, Gao Yuan, Yang Huajing, Li Yun, Liang Juncheng, Zhang Shiyu, Hu Jieying, Zheng Jinping
Abstract excerpt
Background: Chronic obstructive pulmonary disease (COPD) is a prevalent condition that significantly impacts public health. Unfortunately, there are few effective treatment options available. Mendelian randomization (MR) has been utilized to repurpose existing drugs and identify new therapeutic targets. The objective of this study is to identify novel therapeutic targets for COPD. Methods: Cis-expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
